コンテンツへスキップ
Merck

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Nature biotechnology (1997-11-05)
R Zufferey, D Nagy, R J Mandel, L Naldini, D Trono
要旨

Retroviral vectors derived from lentiviruses such as HIV-1 are promising tools for human gene therapy because they mediate the in vivo delivery and long-term expression of transgenes in nondividing tissues. We describe an HIV vector system in which the virulence genes env, vif, vpr, vpu, and nef have been deleted. This multiply attenuated vector conserved the ability to transduce growth-arrested cells and monocyte-derived macrophages in culture, and could efficiently deliver genes in vivo into adult neurons. These data demonstrate the potential of lentiviral vectors in human gene therapy.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
MISSION® pLKO.1-puro eGFP shRNAコントロールプラスミドDNA, shRNA sequence targeting eGFP
Sigma-Aldrich
MISSION ®TurboGFP shRNA コントロールベクター, shRNA sequence targeting tGFP
Sigma-Aldrich
MISSION® shRNAヒト遺伝子ファミリーセット、レンチウイルス粒子, Nuclear Hormone Receptors
Sigma-Aldrich
MISSION® shRNAヒト遺伝子ファミリーセット、レンチウイルス粒子, Cytokine and Chemokine Receptors
Sigma-Aldrich
MISSION® shRNAヒト遺伝子ファミリーセット、レンチウイルス粒子, Apoptosis Pathway
Sigma-Aldrich
MISSION® shRNAヒト遺伝子ファミリーセット、レンチウイルス粒子, Ion Channels
Sigma-Aldrich
MISSION® shRNAヒト遺伝子ファミリーセット、レンチウイルス粒子, Cytokines and Chemokines
Sigma-Aldrich
MISSION® shRNAヒト遺伝子ファミリーセット、レンチウイルス粒子, G-Protein Coupled Receptors
Sigma-Aldrich
MISSION® shRNAヒト遺伝子ファミリーセット、レンチウイルス粒子, Kinases